Rolf Bambauer

University of Saarland, Dialysis and Nephrology, Emeritus

Followers

Following

Co-authors

Public Views

Curriculum VitaeRolf Bambauer, M.D., Ph.D.,Born: 20. June 1943Home Address: Frankenstrasse 4, 66424 Homburg/Saar, GermanyTelephone: 0049/6841/68500, Fax: 0049/68416/68561 E-Mail: [email protected]: 1969 – 1974: University of Saarland, Saarbrücken, GermanyPostgraduate Training: 1975 – 1982: Internal Medicine, Fellow in Nephrology, University of Saarland , 66424 Homburg/Saar, GermanyScientific Certification: 1976: Medical Doctor, 1985: Habilitation, PrivatdozentProfessional Experience: 1980 – 1990: Head of the Department of Nephrology, University of Saarland, Homburg/Saar, Germany. 1990 – 2008: Private praxis, Institute for Blood Purifica-tion with Dialysis and Apheresis, Homburg/Saar, Germany. Research Activition: Therapeutic Plasma Exchange, LDL-Apheresis, Immunoadsorption, Vascular Access, Catheter Technology, Dialysis Technology, Cancer Therapy. Scientific Activities: 270 Publications, 6 Books, 10 Special Issues, 345 Oral Presentations (most in English). Since 2008: RetirementHomburg, 18.1.2018

less

InterestsView All (7)

Uploads

Papers by Rolf Bambauer

Low Density Lipoprotein Apheresis

The Concise Manual of Apheresis Therapy, 2013

Therapeutic plasma exchange volume is usually 3–5 L/session. Removal of positively charged partic... more Therapeutic plasma exchange volume is usually 3–5 L/session. Removal of positively charged particles as well as low density lipoprotein cholesterol improves focal segmental glomerulosclerosis and peripheral arterial disease. Angiotensin converting enzyme (ACE) inhibitors should be discontinued at least 2–3 days prior to low density lipoprotein (LDL) apheresis. LDL apheresis should be performed with careful attention to its promotion of bleeding tendencies because of the adsorption of endogenous coagulation factors.

Surface-Treated versus Untreated Large-Bore Catheters as Vascular Access in Hemodialysis and Apheresis Treatments

Vide Leaf, Hyderabad eBooks, 2020

Background. Catheter-related infections, thrombosis, and stenosis are among the most frequent com... more Background. Catheter-related infections, thrombosis, and stenosis are among the most frequent complications associated with catheters, which are inserted in vessels. Surface treatment processes of the outer surface, such as ion-beam-assisted deposition, can be used to mitigate such complications. Methods. This retrospective study (1992-2007) evaluated silver-coated (54 patients) and noncoated (105 patients) implanted large-bore catheters used for extracorporeal detoxification. The catheters were inserted into the internal jugular or subclavian veins. After removal, the catheters were cultured for bacterial colonization using standard microbiologic assays. They also were examined using scanning electron microscope. Results. The silver coated catheters showed a tendency towards longer in situ time. The microbiologic examinations of the catheter tips were in both catheter types high positive, but not significant. Conclusion. The silver-coated catheters showed no significantly reduction in infection rate by evaluation of all collected data in this retrospective study. There was no association between both catheters in significantly reducing savings in treatment costs and in reducing patient discomfort. Other new developed catheter materials such as the microdomain-structured inner and outer surface are considered more biocompatible because they mimic the structure of natural biological surface.

Rolf Bambauer

Uploads

Papers by Rolf Bambauer

Log In